Search Results for: "Other News to Note"
-
Other News To Note
In other news, Addex said dipraglurant demonstrated dose-dependent mGlu5 receptor occupancy in a nonhuman primate positron emission tomography study, showing the correlation between the plasma concentration of dipraglurant and occupancy of dipraglurant on mGlu5 receptors in the brain...The goal is to validate emerging epigenetic targets for oncology indications and to demonstrate the eligibility of selected target families for drug formalationsBioWorld International | Wednesday, May 8, 2013 -
Pharma: Other News To Note
Takeda Pharmaceuticals Ltd., of Osaka, Japan, said that in the case of Jack Cooper, et al...Takeda Pharmaceuticals America, Inc., et al., the judge granted Takeda's motion for nonsuitBioWorld Today | Friday, May 3, 2013 -
Other News To Note
Heptares Therapeutics Ltd., of Welwyn Garden City, UK, said it has achieved all the milestones in its collaboration with Takeda Pharmaceutical Co., of Osaka, Japan, that focused on a single G protein-coupled receptor (GPCR) target involved in schizophreniaBioWorld International | Wednesday, May 1, 2013 -
Pharma: Other News To Note
Takeda Pharmaceuticals U.S.A. Inc., of Deerfield, Ill., said in the case of Jack Cooper et al...Takeda Pharmaceuticals America, Inc., et al., NoBioWorld Today | Tuesday, April 30, 2013 -
Other News To Note
Heptares Therapeutics Ltd., of Welwyn Garden City, UK, said it has achieved all the milestones in its collaboration with Takeda Pharmaceutical Co., of Osaka, Japan, that focused on a single G protein-coupled receptor (GPCR) target involved in schizophreniaBioWorld Today | Tuesday, April 30, 2013 -
Other News To Note
Affymax Inc., of Palo Alto, Calif., and Takeda Pharmaceutical CoBioWorld Today | Friday, April 12, 2013 -
Other News To Note
The investigation is related to a Feb. 23 announcement from Affymax and partner Takeda Pharmaceutical CoBioWorld Today | Friday, March 15, 2013 -
Pharma: Other News To Note
Takeda Pharmaceutical Co., of Tokyo, and the Scripps Research Institute announced plans to expand their recent research collaboration to search for new drug targets for a variety of diseasesBioWorld Today | Thursday, March 14, 2013 -
Other News To Note
Clinigen Group plc, of Burton-on-Trent, UK, and Theravance Inc., of South San Francisco, entered an exclusive commercialization agreement in the European Union and certain other countries located in Europe for Vibativ (telavancin) in nosocomial pneumonia, including ventilator-associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus, when other alternatives are not suitable...In other news, Elan said its Tysabri (natalizumab) restructuring transaction isBioWorld International | Wednesday, March 13, 2013 -
Pharma: Other News To Note
Takeda Pharmaceutical CoBioWorld Today | Monday, March 11, 2013 -
Other News To Note
and University of Texas Southwestern – UTSW, along with two pharmaceutical firms, Takeda Pharmaceuticals CoBioWorld Today | Friday, February 15, 2013 -
Pharma: Other News To Note
Breckenridge launched its abbreviated new drug application (ANDA) prior to patent expiration pursuant to a settlement of patent litigation with Osaka, Japan-based Takeda Pharmaceutical Co...and Takeda Pharmaceuticals North America Inc., which granted Breckenridge and Synthon a license to applicable patents to sell and distribute its ANDABioWorld Today | Thursday, February 14, 2013 -
Other News To Note
Pursuant to the terms, each of the company's ordinary shares, including shares represented by American depositary shares (ADS), will be cancelled in exchange for the right to receive $2.20 in each per share, or $15.40 per ADS...Due to the oversubscription, the closing unit price was set at NIS3.544 per unitBioWorld International | Wednesday, February 13, 2013 -
Other News To Note
iron therapy, for iron deficiency anemia, by Takeda UK, of High Wycombe, UK, a unit of Takeda Pharmaceutical CoBioWorld Today | Tuesday, February 12, 2013 -
Pharma: Other News To Note
Sucampo Pharmaceuticals Inc., of Bethesda, Md., and its affiliate Sucampo AG, R-Tech Ueno Ltd., of Tokyo, Takeda Pharmaceutical ColBioWorld Today | Monday, February 11, 2013 -
Other News To Note
Under the agreement, Pepscan will use its CLIPS platform and other protein mimicry technologies to help discover new antibodies...to purchase up to 1 million shares, or about 1.06 percent of the company's outstanding stock, at a price of $161.25 per share, marking a 4.46 percent discount to the Dec. 27 closing priceBioWorld Today | Tuesday, January 8, 2013 -
Other News To Note
Affymax Inc., of Palo Alto, Calif., and Takeda Pharmaceutical CoBioWorld Today | Friday, January 4, 2013 -
Other News To Note
Takeda Pharmaceutical CoBioWorld International | Wednesday, January 2, 2013 -
Other News To Note
Amylin Pharmaceuticals Inc., of Deerfield, Ill., and Takeda Pharmaceutical Co...Infinity Pharmaceuticals Inc., of Cambridge, Mass., amended its agreement with Millennium: The Takeda Oncology Company and Takeda Pharmaceutical CoBioWorld Today | Thursday, December 27, 2012 -
Pharma: Other News To Note
Takeda Pharmaceutical CoBioWorld Today | Tuesday, December 18, 2012
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.